David Kirn - Net Worth and Insider Trading
David Kirn Net Worth
The estimated net worth of David Kirn is at least $25 Million dollars as of 2023-12-04. David Kirn is the CEO of 4D Molecular Therapeutics Inc and owns about 1,859,153 shares of 4D Molecular Therapeutics Inc (FDMT) stock worth over $25 Million. Details can be seen in David Kirn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Kirn has not made any transactions after 2023-02-22 and currently still holds the listed stock(s).
Transaction Summary of David Kirn
David Kirn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Kirn owns 1 companies in total, including 4D Molecular Therapeutics Inc () .
Insider Ownership Summary of David Kirn
|Ticker||Comapny||Transaction Date||Type of Owner|
|4D Molecular Therapeutics Inc||2023-05-02||director & Chief Executive Officer|
David Kirn Latest Holdings Summary
David Kirn currently owns a total of 1 stock. David Kirn owns 1,859,153 shares of 4D Molecular Therapeutics Inc (FDMT) as of February 22, 2023, with a value of $25 Million.
David Kirn Form 4 Trading Tracker
According to the SEC Form 4 filings, David Kirn has made a total of 3 transactions in 4D Molecular Therapeutics Inc (FDMT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in 4D Molecular Therapeutics Inc is the sale of 34,446 shares on February 22, 2023, which brought David Kirn around $709,932.
Insider Trading History of David Kirn
David Kirn Trading Performance
David Kirn Ownership Network
Ownership Network List of David Kirn
Ownership Network Relation of David Kirn
David Kirn Owned Company Details
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
David Kirn is the director & Chief Executive Officer of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include See Remarks Uneek Mehra , 10 percent owner Viking Global Opportunities Parent Gp Llc , and 10 percent owner Viking Global Investors Lp .
4D Molecular Therapeutics Inc () Insider Trades Summary
Over the past 18 months, David Kirn made 3 insider transaction in 4D Molecular Therapeutics Inc () with a net sale of 140,847. Other recent insider transactions involving 4D Molecular Therapeutics Inc () include a net sale of 11,998 shares made by Scott Bizily , a net purchase of 850,000 shares made by Viking Global Investors Lp , and a net sale of 5,000 shares made by Jacob Chacko .
In summary, during the past 3 months, insiders sold 0 shares of 4D Molecular Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 157,845 shares of 4D Molecular Therapeutics Inc () were sold and 850,000 shares were bought by its insiders, resulting in a net purchase of 692,155 shares.
4D Molecular Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
David Kirn Mailing Address
Above is the net worth, insider trading, and ownership report for David Kirn. You might contact David Kirn via mailing address: C/o 4d Molecular Therapeutics Inc., 5858 Horton Street #455, Emeryville Ca 94608.